ABSTRACT Objectives: This study aimed to analyse the cost–utility and budget impact of adding tocilizumab to the standard treatment for patients with refractory systemic juvenile idiopathic arthritis (sJIA) in Thailand. Design: Economic evaluation using a decision-analytical model. Setting:

Abstract Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa

Abstract Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current

In this paper we have reported a five-stage process, including a two-round Delphi survey that developed and reached consensus on a definition of early HTA, which is “a health technology assessment conducted to inform decisions about subsequent development, research and/or investment by explicitly ev

Keywords: Health technology assessment, Rationale, Guideline development   Please follow the link below for full text. You may need to register (free-of-charge) as the article is published in Journal of the Medical Association of Thailand, Vol 91, No 6. http://www.jmatonline.com/index.

Abstract Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current

The WHO report says there were over 26,000 measles cases in 36 European countries from January to October 2011.Western European countries reported 83% of those cases, with 14,000 in France alone.In England and Wales, there were just under 1,000 confirmed measles cases in that period – compared with

Experts, who studied more than 10,000 people across Europe, found those with the gene ABCC9 need around 30 minutes more sleep per night than those without the gene.The gene is carried by one in five Europeans, they say in their study, published in Molecular Psychiatry.The researchers said the findin

The benchside tests showed sperm were less able to swim and had changes in the genetic code that they carry. Experts stress this does not mean the same would occur in a real-life setting and say men should not worry unduly. But they are recommending more studies. The preliminary research, published

The National Institute for Health and Clinical Excellence (NICE) says ranibizumab, sold under the brand name Lucentis, is too expensive to use in people with diabetic macular oedema.Charities say they will continue to campaign for the drug to be used. At least 50,000 people in the UK are affected by